Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis
Putri K.S.S.
Lung
Q1Published: 2024Citations: 7
Abstract
OPG can already be detected during the early stages of fibrosis development and responds, both in early- and late-stage fibrosis, to treatment with antifibrotic drugs currently on the market for lung fibrosis. Therefore, OPG should be further investigated as a potential biomarker for lung fibrosis and a potential surrogate marker for treatment effect.
Access to Document
10.1007/s00408-024-00691-5Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
PirfenidoneSciences
NintedanibSciences
MedicineSciences
OsteoprotegerinSciences
FibrosisSciences
LungSciences
Pulmonary fibrosisSciences
Idiopathic pulmonary fibrosisSciences
BiomarkerSciences
Lung fibrosisSciences
BleomycinSciences
In vivoSciences
Ex vivoSciences
Internal medicineSciences
PathologySciences
BiologySciences
ReceptorSciences
ChemotherapySciences
Activator (genetics)Sciences
BiotechnologySciences
BiochemistrySciences